Zdrowie i gospodarka · 16/02/2005

FDA's Cellular, Tissue and Gene Therapies Advisory Committee to Review Amendment of Notice

The FDA's Cellular, Tissue and Gene Therapies Advisory Committee will review an amendment to a notice, following a request from the agency to update the guidance for biological response modifiers